Patent · US Active

Drug eluting expandable devices

US9949944B2 · kind B2 · utility

0Cited by
22References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2015
Grant dateApr 24, 2018
Priority date
Expiry dateSep 1, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/802
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.